AIM ImmunoTech Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Ocala, FL
AIM chart
What traders are saying about $AIM
Latest postsAIM ImmunoTech Inc. news
- aim immunoTech CEO buys $2,014 in company stock By Investing.com
Investing.com Nigeria ·
- Form 4 AIM ImmunoTech Inc: Thomas K. Equels (Director, CEO & President) For: 6 November
Investing.com UK ·
- At $0.158 a share, AIM ImmunoTech (AIM) CEO Thomas K. Equels buys 12,751 shares.
Stock Titan ·
- AIM ImmunoTech (AIM) Stock Price, Chart & Analysis
www.debelegger.nl ·
- aim immunoTech CEO Equels buys $3,166 in company stock
Investing.com ·
- At $0.1560 per share, AIM ImmunoTech (AIM) CEO buys 20,299 shares.
Stock Titan ·
- AIM ImmunoTech Inc. (AIM) Seasonal returns chart
Yahoo Finance UK ·
- AIM ImmunoTech Highlights Ampligen® Opportunity to
GlobeNewswire ·
- AIM ImmunoTech Inc (HXB.MU) Seasonal returns chart
Yahoo Finance UK ·
- AIM ImmunoTech Furnishes Corporate Presentation on Ampligen Opportunity
TipRanks ·
- AIM ImmunoTech Highlights Ampligen® Opportunity to Potentially Extend Benefits of RAS-Targeted Therapies in Pancreatic Cancer
Yahoo Finance ·
- A pancreatic cancer drug showed median survival of 13.2 months vs. 6.7 with chemo. AIM proposes an immune-drug pairing.
Stock Titan ·
AIM ImmunoTech Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $88,000 | $170,000 | $202,000 | $141,000 |
| Net income | -$14.0M | -$17.3M | -$29.0M | -$19.4M |
| Diluted EPS | $-8.62 | $-30.92 | $-0.60 | $-0.40 |
| Total assets (year end) | $5.8M | $8.6M | $19.4M | $40.5M |
| Cash and equivalents (year end) | $3.0M | $1.7M | $5.4M | $27.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About AIM ImmunoTech Inc.
- Ticker
- AIM (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Ocala, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 946644
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
Frequently asked questions
What exchange is AIM ImmunoTech Inc. listed on?
AIM ImmunoTech Inc. trades on the NYSE under the ticker symbol AIM.
What industry is AIM ImmunoTech Inc. in?
AIM ImmunoTech Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is AIM ImmunoTech Inc. headquartered?
AIM ImmunoTech Inc.'s business address on file with the SEC is in Ocala, FL.
When does AIM ImmunoTech Inc.'s fiscal year end?
AIM ImmunoTech Inc.'s fiscal year ends on December 31.
How much revenue did AIM ImmunoTech Inc. report?
AIM ImmunoTech Inc. reported $88,000 in revenue for calendar year 2025, according to its SEC filings.